Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for CELZ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 9.378M
March 31, 2026 6.441M
December 31, 2025 7.810M
September 30, 2025 5.853M
June 30, 2025 7.105M
March 31, 2025 8.347M
December 31, 2024 6.669M
September 30, 2024 6.888M
June 30, 2024 7.990M
March 31, 2024 9.620M
December 31, 2023 10.72M
September 30, 2023 12.51M
June 30, 2023 14.13M
March 31, 2023 15.23M
December 31, 2022 19.19M
September 30, 2022 22.47M
June 30, 2022 23.43M
March 31, 2022 9.734M
December 31, 2021 11.27M
September 30, 2021 3.132M
June 30, 2021 0.7323M
March 31, 2021 0.8719M
December 31, 2020 0.7178M
September 30, 2020 0.4252M
June 30, 2020 0.4429M
Date Value
March 31, 2020 0.4693M
December 31, 2019 0.5308M
September 30, 2019 0.3304M
June 30, 2019 0.358M
March 31, 2019 0.5779M
December 31, 2018 0.4772M
September 30, 2018 0.3556M
June 30, 2018 0.2794M
March 31, 2018 0.2913M
December 31, 2017 0.2031M
September 30, 2017 0.2112M
June 30, 2017 0.2996M
March 31, 2017 0.1961M
December 31, 2016 0.3225M
September 30, 2016 0.1367M
June 30, 2016 0.1217M
March 31, 2016 0.0002M
December 31, 2015 0.0002M
September 30, 2015 0.0007M
June 30, 2015 0.0006M
March 31, 2015 0.0006M
December 31, 2014 0.001M
September 30, 2014 0.0013M
June 30, 2014 0.0013M
March 31, 2014 0.0013M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 1.743B
Alnylam Pharmaceuticals, Inc. 5.559B
Anika Therapeutics, Inc. 183.47M
Savara, Inc. 192.14M
Vericel Corp. 502.87M

Total Assets (Quarterly) Related Metrics